PR Newswire
Wed, Jun 18, 2025, 12:19 PM 3 min read
, /PRNewswire/ -- RevelAi Health, a conversational artificial intelligence (AI) platform built for musculoskeletal care, has closed an oversubscribed $3.1 million seed round led by Ulu Ventures and Symphonic Capital, with participation from Orthopedic VC, Sand Hill Angels, and a consortium of nationally recognized orthopedic surgeons.
Musculoskeletal disorders now account for the largest share of U.S. health-care spending—exceeding $420 billion annually—while the country faces a projected shortage of up to 86,000 physicians by 2036. Meanwhile, the Centers for Medicare & Medicaid Services (CMS) is moving hospitals toward mandatory downside-risk bundles for joint replacement, fracture care, and other orthopedic episodes, aiming for universal value-based coverage by 2030.
"Musculoskeletal care is shifting from single-visit encounters to population-level accountability just as clinical teams are stretched thin," said Christian Pean, MD, MS, orthopedic trauma surgeon, faculty member at the Duke-Margolis Institute for Health Policy, and Founder & Chief Executive Officer of RevelAi Health. "RevelAi gives organizations an AI-first operating layer that lets them succeed in that reality."
RevelAi functions as a 24/7 virtual care navigator for orthopedic practices and care organizations: it answers calls with evidence-based triage, collects mandated quality reporting questionnaires by voice or text, and converts every phone, video, or in-person encounter into a structured note with clinical documentation codes and automated risk flags. Episode-wide workflows trigger Principal Care Management, Transitional Care Management, and preoperative optimization tasks that align each patient's journey with CMS's new Transforming Episode Accountability Model (TEAM) bundled payment model and other value-based initiatives—without extra staff clicks. All clinical content and decision logic are continuously refined by RevelAi's advisory group of board-certified orthopedic surgeons, ensuring each recommendation remains guideline-concordant and purpose-built to accelerate value-based musculoskeletal care.
"RevelAi's AI agents close care gaps, curb avoidable emergency department visits, and simplify quality reporting—without adding staff," said Ronald Delanois, MD, Chairman of the Rubin Institute for Advanced Orthopedics at LifeBridge Health in Baltimore, Maryland.
From my perspective, conversational AI is essential for succeeding in value-based mandates like the Transforming Episode Accountability Model", said Joseph Zuckerman, MD, Chair of Orthopedic Surgery at NYU Langone Health.
English (US) ·